| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.76B | +5.7% |
| Cost of Revenue | $1.27B | +4.8% |
| Gross Profit | $498.3M | +7.8% |
| R&D Expense | $40.7M | +0.2% |
| SG&A Expense | $184.3M | -1.8% |
| Operating Income | $299.0M | +12.3% |
| Pre-tax Income | $266.2M | +13.4% |
| Income Tax | $58.8M | +19.5% |
| Net Income | $207.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.4M | +28.3% |
| Accounts Receivable | $320.1M | +25.9% |
| Inventory | $282.3M | +5.9% |
| Current Assets | $892.4M | +18.2% |
| Total Assets | $1.35B | +13.5% |
| Current Liabilities | $368.2M | +6.8% |
| Long-term Debt | $570.0M | -3.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $202.7M | +92.3% |
| Capital Expenditures | $53.9M | +10.9% |
| Investing Cash Flow | -$53.9M | -10.9% |
| Financing Cash Flow | -$101.7M | -184.1% |
| Free Cash Flow | $148.8M | +162.0% |
| +11.7% |
| EPS (Basic) | $2.52 | +13.0% |
| EPS (Diluted) | $2.50 | +12.6% |
| Total Liabilities |
| $972.2M |
| +1.0% |
| Stockholders' Equity | $378.5M | +66.4% |